Arcturus Therapeutics In... (ARCT)

ARCT trades at $22.56, 28.9% above the near-term max pain of $17.5 expiring Oct 17, 2025 (13 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($7-$20), reflecting growing call interest at higher strikes. Key magnetic zone at 18 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for ARCT shows an upward trend from 7 to 20, suggesting bullish positioning in longer-dated options. The 84% spread signals divergent expectations across timeframes. Most levels below 22.56 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.